AsianScientist (Oct. 10, 2016) – US-based Intuitive Surgical, Inc. and healthcare group Shanghai Fosun Pharmaceutical (Fosun Pharma) have announced a joint venture to research, develop, manufacture and sell robotic-assisted, catheter-based medical devices.
The joint venture between Intuitive Surgical, a company focusing on robotic-assisted minimally invasive surgery, and Fosun Pharma will initially produce products targeting early diagnosis and cost-effective treatment of lung cancer, one of the most commonly diagnosed forms of cancer in the world.
The technology will be used in robotic-assisted medical devices based on catheters, and incorporates proprietary intellectual property developed or owned by Intuitive Surgical. The joint venture will be registered in Shanghai, where it will perform research and development activities and manufacture catheter-based products for global distribution.
The companies will contribute up to US$100 million as required by the joint venture, an arrangement representing a significant expansion of Intuitive Surgical’s relationship with Fosun Pharma.
Distribution in China will be conducted by the joint venture, while distribution outside of China will be conducted by Intuitive Surgical.
———
Source: Intuitive Surgical, Inc.; Photo: Intuitive Surgical, Fosun Pharma.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
